Abstract
The outer membrane of the cell wall of Gram-negative bacteria is a protective layer that controls the entry of many large molecules and protects the cell from potentially damaging agents. For those bacteria that come in contact with animals an important component of the Gram-negative outer membrane is lipopolysaccharide (LPS), a complex molecule not found elsewhere in nature. LPS, also termed endotoxin, represents the main surface antigen (O-antigen) for Gram-negative bacteria. The term endotoxin was coined by Pfeiffer in 1982, when he noted that certain toxic material was not excreted from living bacteria, as an exotoxin, but rather was released when the bacteria underwent lysis1. LPS is firmly bound to the bacterial cell and is composed of three main domains2 (Fig. 1). An outer polysaccharide chain, called the O-specific chain, contributes to the antigenicity and serospecificity of the molecule and is composed of repeating units that may contain up to seven different sugars. This O-specific chain is thus a polymer of identical repeating units, and is of large size since it can be up to 50 repeating units in length. The second component of the molecule is a short series of core sugars (approximately 10–15) while the innermost lipid component, termed lipid A, anchors LPS in the outer leaflet of the membrane. The fatty acids in lipid A vary with the microbial species, and endow hydrophobicity to the molecules. Thus LPS is an essential structure of all Gram-negative bacteria whether their natural habitat is salt lakes, ocean sediments, root nodules or the human gut. LPS is not a specific component to bacterial pathogens, rather it is a universal component of these organisms, be they friend or foe.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Rietschel ET, Brade H. Bacterial endotoxins. Sci Am. 1992; 267: 54–61.
Rietschel ET, Brade L, Holst O et al. Molecular structure of bacterial endotoxin in relation to bioactivity. In: Nowotny A, Spitzer JJ, Ziegler EJ, editors. Cellular and molecular aspects of endotoxin reactions. Amsterdam: Elsevier; 1990: 15–32.
Bocci V. The neglected organ: bacterial flora has a crucial immunostimulatory role. Prospect Biol Med. 1992; 35: 249–58.
Perez Perez GI, Blaser MJ. Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun 1987; 55: 1256–63.
Cohen PS, Arruda JC, Williams TJ, Laux DC. Adhesion of a human faecal Escherichia coli strain to mouse colonic mucus. Infect Immun. 1985; 48: 139–45.
Myhal ML, Cohen PS, Laux DC. Altered colonising ability for mouse large intestine of a surface mutant of a human faecal isolate of Escherichia coli. J Gen Microbiol. 1993; 129: 1549–58.
Moran AP, Helander IM, Kosunen TU. Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J Bacteriol. 1992; 174: 1370–7.
Moran AP, Walsh EJ. Expression and electrophoretic characterisation of smooth-form lipopolysaccharides of Helicobacter pylori. Acta Gastroenterol Belg. 1993; 56 (S): 97.
Mattsby-Baltzer I, Mielniczuk Z, Larsson L, Lindgren K, Goodwin S. Lipid-A in Helicobacter pylori. Infect Immun. 1992; 60: 4383–7.
Weintraub A, Zahringer U, Wollenweber HW, Seydel U, Rietschel ET. Structural characterisation of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Eur J Biochem. 1989; 183: 425–31.
Hazen SL, Lee A, Brady L, Hennessy W. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis. 1986; 153: 658–63.
Steer HW. The gastro-duodenal epithelium in peptic ulceration. J Pathol. 1985; 146: 355–62.
Thomsen LL, Gavin JB, Tasman Jones C. Relation of Helicobacter pylori to the human gastric mucosa in chronic gastritis of the antrum. Gut. 1990; 31: 1230–6.
Mai UE, Perez Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharideindependent mechanism. J Clin Invest. 1991; 87: 894–900.
Blaser MJ. Hypothesis on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology. 1992; 102: 720–7.
Trust TJ, Doig P, Emody L, Kienle Z, Wadstrom T, O’Toole P. High affinity binding of the basement membrane proteins collagen type IV and laminin to the gastric pathogen Helicobacter pylori. Infect Immun. 1991; 59: 4398–404.
Slomiany BL, Piotrowski J, Sengupta S, Slomiany A. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide. Biochem Biophys Res Commun. 1991; 175: 963–70.
Slomiany BL, Piotrowski J, Rajiah G, Slomiany A. Inhibition of gastric mucosa laminin receptor by Helicobacter pylori lipopolysaccharide: effect of nitecapone. Gen Pharmacol. 1991; 22: 1063–9.
Piotrowski J, Yamaki K, Slomiany A, Slomiany BL. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori: effect of sucralfate. Am J Gastroenterol. 1991; 86: 1756–60.
Piotrowski J, Morita M, Slomiany A, Slomiany BL. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide - effect of ebrotidine. Biochem Int. 1992; 27: 131–8.
Slomiany A, Piotrowski J, Yotsumoto F, Czajkowski A, Slomiany BL. H. pylori lipopolysaccharide inhibition of gastric mucosal laminin receptor: effect of sulglycotide. Acta Gastroenterol Belg. 1993; 65 (suppl.): 120.
Valkonen KH, Ringner M, Ljungh A, Wadstrom T. High-affinity binding of laminin by Helicobacter pylori - evidence for a lectin-like interaction. FEMS Immunol Med Microbiol. 1993; 7: 29–37.
Moran AP, Kuusela P, Kosunen TU. Interaction of Helicobacter pylori with extracellular matrix proteins. J Appl Bacteriol. 1993; 75: 184–9.
Glass GBJ, Slomiany BL. Derangements of biosynthesis, production and secretion of mucus in gastrointestinal injury and disease. In: Elstein M, Parke DV, editors. Mucus in health and disease. New York: Plenum Press; 1977: 311–47.
Murakami S, Mori Y. Changes in the incorporating activity of 35S-sulphate into gastric sulfated glycoproteins in the rat with erosions by restraint and water immersion stress. Jpn J Pharmacol. 1984; 35: 279–86.
Azumi Y, Ohara S, Ishihara K, Okabe H, Hotta K. Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats. Gut. 1980; 21: 533–6.
Younan F, Pearson J, Allen A, Venables C. Changes in the structure of the mucous gel on the mucosal surface of the stomach in association with peptic ulcer disease. Gastroenterology. 1982; 82: 827–31.
Slomiany BL, Liau YH, Lopez RA, Piotrowski J, Czajkowski A, Slomiany A. Effect of Helicobacter pylori lipopolysaccharide on the synthesis of sulfated gastric mucin. Biochem Int. 1992; 27: 687–97.
Pearson JP, Ward R, Allen A, Roberts NB, Taylor WH. Mucus degradation by pepsin: comparison of mucolytic activity of human pepsin 1 and pepsin 3: implications in peptic ulceration. Gut. 1986; 27: 243–8.
Venables CW. Mucus, pepsin, and peptic ulcer. Gut. 1986; 27: 233–8.
Waldrum HL, Burhol PG, Straume BK. Serum group I pepsinogens and gastrin in relation to gastric H+ and pepsin outputs before and after subcutaneous injection of pentagastrin. Scand J Gastroenterol. 1978; 13: 943–6.
Sumii K, Inbe A, Uemura N et al. Increased serum pepsinogen 1 and recurrence of duodenal ulcer. Scand J Gastroenterol. 1989; 24: 1200–4.
Samloff IM, Stemmermann GN, Heilbrun LK, Nomura A. Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterology. 1986; 90: 570–6.
Young GO, Stemmet N, Lastovica A et al. Helicobacter pylori lipopolysaccharide stimulates mucosal pepsinogen secretion. Aliment Pharmacol Ther. 1992; 6: 169–77.
Cave TR, Cave DR. Helicobacter pylori stimulates pepsin secretion from isolated rabbit gastric glands. Scand J Gastroenterol. 1991; 26: 9–14.
Muotiala A, Helander IM. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun 1992; 60: 1714–16.
Birkholz S, Knipp U, Nietzki C, Adamek RJ, Opferkuch W. Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria. FEMS Immunol Med Microbiol. 1993; 6: 317–24.
Kauffman F. The bacteriology of the Enterobacteriaeceae. Copenhagen: Munksgaard; 1966: 55–309.
Penner JL, Hennessy JN. Possible haemagglutination technique for serotyping Campylobacter fetus subs. jejuni on the basis of heat-stable antigens. J Clin Microbiol. 1983; 12: 732–7.
Mills SD, Kurjanczyk LA, Penner JL. Antigenicity of Helicobacter pylori lipopolysaccharides. J Clin Microbiol. 1992; 30: 3175–80.
Crabtree JE, Plusa S, Farmery S, Peichl P, Lindley IJD. Cytokine regulation of interleukin-8 secretion by gastric epithelial cell lines. Acta Gastroenterol Belg. 1993; 56 (S): 52.
Crabtree JE, Farmery S, Lindley IJD, Peichl P. Cytotoxic strains of Helicobacter pylori induce IL-8 production by gastric epithelial cells. Acta Gastroenterol Belg. 1993; 56 (S): 48.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Lee, A., Moran, A.P. (1994). Lipopolysaccharide (LPS)-related damage by H. pylori . In: Hunt, R.H., Tytgat, G.N.J. (eds) Helicobacter pylori. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1418-9_13
Download citation
DOI: https://doi.org/10.1007/978-94-011-1418-9_13
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4620-6
Online ISBN: 978-94-011-1418-9
eBook Packages: Springer Book Archive